Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia.

K, Ohnishi; H, Yoshida; K, Shigeno; S, Nakamura; S, Fujisawa; K, Naito; K, Shinjo; Y, Fujita; H, Matsui; A, Takeshita; S, Sugiyama; H, Satoh; H, Terada; R, Ohno

doi:10.7326/0003-4819-133-11-200012050-00012

Public

Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia.

Shared by NobleBlocks on Dec 1, 2000 • 12:00 AM UTC

Authors:

Ohnishi K

Yoshida H

Shigeno K

Abstract

<h4>Background</h4>Recently, arsenic trioxide has increasingly been used for relapsed acute promyelocytic leukemia. However, it is known to have several adverse effects, including acute cardiac toxicities.<h4>Objective</h4>To determine cardiac toxicities resulting from arsenic trioxide therapy in pa...

Discussions